There are no translations available.
2011: A VERY SATISFACTORY ECONOMIC BALANCE SHEET
2011 as 2010 was a very tricky year for in vitro diagnostic companies: crisis is everywhere. However, DIAGAST plays its game well in 2011 by posting an increase of 15% of its turnover and keeps going by confirming excellent results in spite of the economic context.
Innovating is daring, daring is winning!
Innovation is more than a simple word in the "diagastian" vocabulary: it is our state of mind. Indeed, innovation is not the monopoly of R&D: it is everywhere, in all the fields. With creativity and proposition forces, employees succeed the amazing gamble of breaking the frame to progress.
Our approach of the international market is that of « challengers”: a methodology fitting a leader with the flexibility of a biotechnology company and the state of mind of a start-up (dynamism and ambition). We are tackling the markets in a very relaxed frame of mind compared to the size of our company (140 employees). That is the reason why we have obtained significant market shares in countries as India, Brazil or Russia.